Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

Fill Out & Get More Relevant News

Your name

Your email

Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.
Popular
- Trump dismisses Musk’s political ambitions as ‘ridiculous’ in sharp rebuke
  July 7, 2025
- Don’t Overlook This Lagging Industry; I Believe It’s Set To Explode!
  July 7, 2025

Trump dismisses Musk’s political ambitions as ‘ridiculous’ in sharp rebuke